About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 401 record(s)
Req # A-2023-000230
All documents submitted by BioNTech Manufacturing Company GmbH or Pfizer as part of the regulatory review that resulted in the Regulatory Decision Summary dated September 16, 2021 for the Comirnaty Vaccine. The full regulatory review decision from which the summary was generated. See https://covid-vaccine.canada.ca/comirnaty/product-detailsOrganization: Health Canada
December 2023
Req # A-2023-000553
Health Canada is currently reviewing an Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient estradiol. Advise if the proposed dosage form of the Estradiol ANDS is a tablet with an oral route of administration.Organization: Health Canada
December 2023
Req # A-2023-000590
All notes made by the Health Canada employees who reviewed the Pfizer-BioNTech Comirnaty COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: August 1, 2021 to December 31, 2021.Organization: Health Canada
December 2023
Req # A-2023-000592
All notes made by the Health Canada employees who reviewed the Pfizer-BioNTech Comirnaty COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2021 to July 31, 2021.Organization: Health Canada
December 2023
Req # A-2023-000593
All notes made by the Health Canada employees who reviewed the Moderna Spikevax COVID-19 vaccines, in relation to the review, that were made during the reviewal process of the drug. Date Range: January 1, 2021 to July 31, 2021.Organization: Health Canada
December 2023
Req # A-2023-000600
All notes made by the Health Canada employees who reviewed the Moderna Spikevax COVID-19 vaccines, in relation to the review, that were made during the reviewal process of the drug. Date Range: August 1, 2021 to December 31, 2021.Organization: Health Canada
December 2023
Req # A-2023-000604
All notes made by the Health Canada employees who reviewed the AstraZeneca Vaxzevria COVID-19 vaccine, in relation to the review, that were made during the reviewal process of the drug. Date Range: August 1, 2021 to December 31, 2021.Organization: Health Canada
December 2023
Req # A-2023-000721
All communication between Director Generals, Directors, Executive Director, Assistant Deputy Minister of Pest Management Regulatory Agency and Human Resources Classification, Labor Relation and Human Resources, Staffing about the two AS-05 positions mentions in this request text. All documentation sent to or received from Human Resources Classification, including meeting minutes or notes as of October1, 2022 about the AS-05 Project Coordinator, position number, 165664 and AS-05 Senior Administrative Officer, position number 169135 in the Transformation Group and AS-04 Management Administrative Officers, position number, 90432, 146620, 90326, 149635, 90271 and 90053 of the Pest Management Regulatory Agency.Organization: Health Canada
December 2023
Req # A-2023-000747
Inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Manufacturing Practices (GMP) inspection of Bausch Health Companies (Site B) on Boul. St. Elzear Ouest, Quebec starting around 11 July 2022. Reference Number 500855.Organization: Health Canada
December 2023
Req # A-2023-000986
Information concerning the status of this company with your organization. Dynatool Industries Inc.3540 Saint-Patrick Street, Montréal, Quebec H4E 1A2Organization: Health Canada
December 2023